Neuspera Medical has obtained U.S. Food and Drug Administration (FDA) approval for its integrated sacral neuromodulation (iSNM) system to treat urinary urge incontinence (UUI).
The iSNM system provides UUI patients an alternative to a traditional...
Neuspera Medical has obtained U.S. Food and Drug Administration (FDA) approval for its integrated sacral neuromodulation (iSNM) system to treat urinary urge incontinence (UUI).
The...
Levita Magnetics announced that it received expanded FDA 510(k) clearance for its MARS (magnetic-assisted robotic surgery) system.
The FDA granted 510(k) clearance for its Magnetic...
ANACONDA Biomed, a medical technology company developing next-generation thrombectomy systems for the treatment of ischemic stroke, has announced that it has received CE Mark...
Corvia Medical has raised $55m to complete an ongoing clinical trial of its atrial shunt system for heart failure.
The US-based company’s trial began in...
FineHeart announced French regulators gave it the green light to initiate a first-in-human heart device trial in France.
The French National Agency for the Safety...
NeuroPace announced preliminary one-year results from its Nautilus clinical study evaluating neuromodulation therapy for idiopathic generalised epilepsy (IGE).
The company said the study met its...
Inner Cosmos recently reported interim 36-month outcomes from a study of its psychiatric brain-computer interface technology. The company evaluated the safety and feasibility of...
Neuspera Medical has obtained U.S. Food and Drug Administration (FDA) approval for its integrated sacral neuromodulation (iSNM) system to treat urinary urge incontinence (UUI).
The...
Levita Magnetics announced that it received expanded FDA 510(k) clearance for its MARS (magnetic-assisted robotic surgery) system.
The FDA granted 510(k) clearance for its Magnetic...
ANACONDA Biomed, a medical technology company developing next-generation thrombectomy systems for the treatment of ischemic stroke, has announced that it has received CE Mark...
Corvia Medical has raised $55m to complete an ongoing clinical trial of its atrial shunt system for heart failure.
The US-based company’s trial began in...